Inpatient Decongestive Therapy for Lymphedema in Acute Postsurgical Head and Neck Cancer Patients*

John Christian Lemoine; Vilija Vaitaitis; Trisha Jarreau; Joel St. Germain; Leslie Son; Anna M. Pou; Ashley Mays

doi:10.1055/s-0042-1745726

International Archives of Otorhinolaryngology, Table of Contents

CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2023; 27(02): e329-e335
DOI: 10.1055/s-0042-1745726

Original Research

Inpatient Decongestive Therapy for Lymphedema in Acute Postsurgical Head and Neck Cancer Patients*

Authors

John Christian Lemoine

¹Department of Otolaryngology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States
Vilija Vaitaitis

²Department of Otolaryngology – Head & Neck Surgery, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States
Trisha Jarreau

³Department of Speech and Language Pathology, Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States
Joel St. Germain

³Department of Speech and Language Pathology, Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States
Leslie Son

⁴Department of Otolaryngology, Our Lady of the Lake Regional Medical Center, Louisiana, United States
Anna M. Pou

⁵Department of Otolaryngology, Ochsner Health Center – Covington, Covington, Louisiana, United States
Ashley Mays

²Department of Otolaryngology – Head & Neck Surgery, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States

Abstract

Introduction Head and neck lymphedema is an omnipresent morbidity related to head and neck cancer therapies. Studies on therapy for these patients in the acute postsurgical population have not been published to date.

Objective To assess changes in the measurements of lymphedema in surgical head and neck cancer patients during the hospital stay with implementation of modified decongestive therapy (MDT).

Methods Patients aged > 18 years undergoing neck dissection with or without primary-site resection or laryngectomy between 2016 and 2019 were included. Facial measurements were obtained prior to beginning MDT and again prior to discharge. A total facial composite measurement was calculated and used to assess change over time. Rates ≥ 2% of change were considered significant.

Results A total of 38 patients were included (subsites: larynx = 27; thyroid = 4; oral cavity = 3; and neck = 4). The mean number of days between surgery and the start of lymphedema therapy was 3.0 days. The mean number of days between measurements was 5.2 days. Reduction in the total composite score was observed in 37 (97%) patients, and 35 (92%) patients had a total composite reduction score > 2%. Tumor subsite and surgery type did not portend toward greater percent change, except for those patients treated with total laryngectomy, regional flap reconstruction, and neck dissection (p = 0.02).

Conclusion Acute postsurgical inpatient MDT was associated with reduced total composite measurements in patients after head and neck surgery. As the first published study on lymphedema therapy in this acute postsurgical period, further prospective case-control studies are warranted to explore further benefits of acute therapy.

Keywords

lymphedema - complete decongestive therapy - head and neck cancer - head and neck surgery - manual lymph drainage

Full Text

References

References
1 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
2 Tyker A, Franco J, Massa ST, Desai SC, Walen SG. Treatment for lymphedema following head and neck cancer therapy: A systematic review. Am J Otolaryngol 2019; 40 (05) 761-769
3 Smith BG, Hutcheson KA, Little LG. et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg 2015; 152 (02) 284-291
4 Foldi M, Foldi E, Strossenruther RH, Kubic S. Lymphostatic diseases. In: Foldi's textbook of lymphology for physicians and lymphedema therapists 2nd ed.,. Munchen, Germany:: Urban and Fischer;; 2006: 224-240
5 Foldi M, Foldi E, Strossenruther RH, Kubic S. Practical instructions for therapists: manual lymph drainage according to Dr. E. Vodder. In: Foldi's textbook of lymphology for physicians and lymphedema therapists 2nd ed.,. Munchen, Germany:: Urban and Fisher;; 2006: 526-546
6 Deng J, Murphy BA, Dietrich MS, Sinard RJ, Mannion K, Ridner SH. Differences of symptoms in head and neck cancer patients with and without lymphedema. Support Care Cancer 2016; 24 (03) 1305-1316
7 Executive Committee of the International Society of Lymphology.. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53 (01) 3-19
8 Ridner SH, Dietrich MS, Niermann K, Cmelak A, Mannion K, Murphy B. A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer. Lymphat Res Biol 2016; 14 (04) 198-205
9 Bruns F, Büntzel J, Mücke R, Schönekaes K, Kisters K, Micke O. Selenium in the treatment of head and neck lymphedema. Med Princ Pract 2004; 13 (04) 185-190
10 Deng J, Ridner SH, Dietrich MS. et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage 2012; 43 (02) 244-252
11 Deng J, Ridner SH, Murphy BA, Dietrich MS. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer. Support Care Cancer 2012; 20 (08) 1911-1918
12 Micke O, Bruns F, Mücke R. et al. Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys 2003; 56 (01) 40-49
13 Smith BG, Lewin JS. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2010; 18 (03) 153-158
14 Penner JL. Psychosocial care of patients with head and neck cancer. Semin Oncol Nurs 2009; 25 (03) 231-241
15 Jeans C, Ward EC, Brown B. et al. Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment. Head Neck 2021; 43 (01) 255-267
16 Nowak P, Parzuchowski J, Jacobs JR. Effects of combined modality therapy of head and neck carcinoma on shoulder and head mobility. J Surg Oncol 1989; 41 (03) 143-147
17 van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL. Morbidity of the neck after head and neck cancer therapy. Head Neck 2004; 26 (09) 785-791
18 Kasseroller RG. The Vodder School: the Vodder method. Cancer 1998; 83 (12) 2840-2842
19 Vodder E. [Vodder's lymph drainage. A new type of chirotherapy for esthetic prophylactic and curative purposes]. Asthet Med (Berl) 1965; 14 (06) 190-191
20 Chikly BJ. Manual techniques addressing the lymphatic system: origins and development. J Am Osteopath Assoc 2005; 105 (10) 457-464
21 Gutierrez C, Karni RJ, Naqvi S. et al. Head and Neck Lymphedema: Treatment Response to Single and Multiple Sessions of Advanced Pneumatic Compression Therapy. Otolaryngol Head Neck Surg 2019; 160 (04) 622-626
22 Tacani PM, Franceschini JP, Tacani RE. et al. Retrospective study of the physical therapy modalities applied in head and neck l ymphedema treatment. Head Neck 2016; 38 (02) 301-308
23 Jeans C, Ward EC, Cartmill B. et al. Patient perceptions of living with head and neck lymphoedema and the impacts to swallowing, voice and speech function. Eur J Cancer Care (Engl) 2019; 28 (01) e12894
24 Pigott A, Nixon J, Fleming J, Porceddu S. Head and neck lymphedema management: Evaluation of a therapy program. Head Neck 2018; 40 (06) 1131-1137